©The Author(s) 2025.
World J Stem Cells. Sep 26, 2025; 17(9): 109102
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.109102
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.109102
Table 3 The effects of non-coding HOX genes in various fibrotic diseases
| HOX genes | Disease | Mode of function in fibrosis | Proof of concept or mechanism of action | Ref. |
| HOTAIR | Liver fibrosis | Pro-fibrotic | HOTAIR upregulation was found to be promoting liver fibrosis in mouse and cell line models. Arsenic exposure was found to induce hepatic fibrosis via T-cell expression of HOTAIR | [177,201,202] |
| Lung fibrosis | Pro-fibrotic | Acts as a competing ceRNA to regulate MMP2 expression during paraquat-induced lung epithelial-mesenchymal transition, promoting fibrosis | [203] | |
| Kidney fibrosis | Pro-fibrotic | In a rat model with TGFβ-treated kidney cells, HOTAIR was elevated in renal fibrosis, driving epithelial-mesenchymal transition via the Notch pathway | [109] | |
| Cardiac fibrosis | Pro-fibrotic | Upregulated in atrial fibrillation and promotes pathological fibrosis in the atrium. In Ang II-treated atrial fibroblasts, HOTAIR and Wnt5a levels increased, and HOTAIR knockdown inhibited fibroblast proliferation, migration, and expression of collagen I/III and α-SMA | [12] | |
| Skin fibrosis | Pro-fibrotic | In systemic sclerosis dermal fibroblasts, HOTAIR is aberrantly upregulated and induces a pro-fibrotic gene program. Overexpression of HOTAIR in healthy skin fibroblasts caused epigenetic silencing of miR-34a via EZH2 (H3K27me3), which activated Notch signaling and secondarily upregulated the Hedgehog effector GLI2 | [91,204] | |
| HOTAIRM1 | Lung fibrosis | Pro-fibrotic | Hypoxia-exposed alveolar epithelial cells secrete pro-fibrotic exosomes enriched in lncRNA HOTAIRM1 | [205] |
| HOTTIP | Liver fibrosis | Pro-fibrotic | Promotes hepatic stellate cell activation through increased SRF expression by sponging miR-150 | [206] |
| Liver fibrosis | Pro-fibrotic | Highly upregulated in fibrotic livers and activated hepatic stellate cells. Increased HOTTIP acts as a sponge for miR-148a, relieving repression of TGFβ receptor genes. Consequently, TGFBR1/2 levels rise, driving HSC activation and collagen production | [112] | |
| Lung fibrosis | Pro-fibrotic | Enhances lung fibrosis by regulating the miR-744-5p/PTBP1 signaling axis | [110] | |
| HOXA11-AS | Liver fibrosis | Pro-fibrotic | Upregulated in a mouse model of ischemia/reperfusion-induced liver fibrosis and exacerbates fibrosis via a PTBP1/HDAC4 mechanism | [167] |
| Cardiac fibrosis | Pro-fibrotic | Drives TGFβ1-mediated cardiac fibroblast activation. Overexpression of HOXA11-AS in mouse cardiac fibroblasts significantly increased TGF-β1 expression and downstream Smad signaling, promoting fibroblast proliferation, colony formation, and invasion, whereas HOXA11-AS knockdown had opposite effects | [106] | |
| Skin fibrosis | Pro-fibrotic | Significantly overexpressed in keloid tissue and fibroblasts, promotes abnormal scar formation by acting as a ceRNA | [207] | |
| miR-10a | Liver fibrosis | Pro-fibrotic | In a CCl4-induced mouse liver fibrosis model, miR-10a was found to exacerbate fibrosis. Overexpression of miR-10a increased TGF-β1/Smad3 signaling and collagen-I expression, whereas miR-10a inhibition ameliorated liver fibrosis | [197] |
| miR-10a/b | Kidney fibrosis | Pro-fibrotic | miR-10 family (miR-10a/10b, located in HOX clusters) is aberrantly expressed in chronic kidney disease. In fibrotic mouse kidneys, miR-10a/b levels are elevated and contribute to fibrosis by targeting VASH1, an anti-angiogenic factor that also inhibits TGF-β/Smad signaling | [114] |
| miR-196a | Lung fibrosis | Anti-fibrotic | In a bleomycin-induced fibrosis model, lncRNA H19 was upregulated and sponged miR-196a, thereby relieving suppression of COL1A1. Silencing H19 reduced fibroblast activation and collagen deposition, an effect reversed by miR-196a inhibition | [208] |
| miR-615-5p | Liver fibrosis | Pro-fibrotic | miR-615-5p expression is significantly upregulated in cirrhotic livers and in plasma of patients with advanced fibrosis compared to healthy controls | [209] |
- Citation: Keleş M, Gunel-Ozcan A. HOX and MEINOX in cellular plasticity, fibrosis, and cancer. World J Stem Cells 2025; 17(9): 109102
- URL: https://www.wjgnet.com/1948-0210/full/v17/i9/109102.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i9.109102